Genetic Sequencing tests in Dubai & UAE

Compare available Genetic Sequencing tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

256

Listed price range

2,600.00–5,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetic Sequencing test prices

Showing 16–30 of 256 matching tests.

Genetic Sequencing diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-2183 ARNT2 Gene Webb‑Dattani Syndrome Genetic Test This diagnostic test evaluates the ARNT2 gene for pathogenic variants associated with Webb‑Dattani syndrome.	Peripheral blood (EDTA), Saliva (Oragene), or FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ARNT2 gene coding sequence", "Single Nucleotide Variants (SNVs)", "Insertions/Deletions (indels)", "Copy Number Variations (CNVs)"] Parameters [] Preparation ["No specific fasting required", "No medication or diet changes needed"] Indications ["Suspected Webb‑Dattani syndrome based on clinical presentation", "Family history of Webb‑Dattani syndrome", "Genetic counseling for families with affected individuals"] Measurement technique Confirm with laboratory Codes LOINC: 82669-0 ICD-10: Q87.8 Clinical summary This diagnostic test evaluates the ARNT2 gene for pathogenic variants associated with Webb‑Dattani syndrome.
TEST-5984 ARSB Gene Mucopolysaccharidosis Type 6 Genetic Test This test identifies pathogenic variants in the ARSB gene associated with Mucopolysaccharidosis Type 6 (Maroteaux-Lamy syndrome). It uses next-generation sequencing to analyze the...	Peripheral Blood, Extracted DNA, or FTA Card (Finger-prick)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ARSB gene", "Single-nucleotide resolution across the ARSB coding region"] Parameters [] Preparation ["No fasting required", "Mandatory pre-test genetic counselling session"] Indications ["Confirmation of suspected Mucopolysaccharidosis Type 6 (Maroteaux-Lamy syndrome)", "Evaluation of metabolic disorder", "Carrier testing for family members"] Measurement technique Confirm with laboratory Codes LOINC: 94044-9 ICD-10: E76.2 Clinical summary This test identifies pathogenic variants in the ARSB gene associated with Mucopolysaccharidosis Type 6 (Maroteaux-Lamy syndrome). It uses next-generation sequencing to analyze the entire coding region.
TEST-2727 Ataxia-Telangiectasia Genetic Testing (NGS with Sanger Confirmation) Test This test identifies pathogenic variants in the ATM gene, confirming a diagnosis of Ataxia-Telangiectasia.	Peripheral whole blood (Lavender-top EDTA tubes)	40 working days	2,600.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ATM gene variants", "Single-nucleotide variants", "Small insertions/deletions", "Exon-level copy-number changes"] Parameters [] Preparation ["Do not discontinue prescribed therapy without physician instruction", "Testing in children requires prior clinical assessment by a specialist"] Indications ["Suspected Ataxia-Telangiectasia", "Progressive cerebellar ataxia", "Immunodeficiency", "Elevated cancer risk"] Measurement technique Confirm with laboratory Codes LOINC: 92041-1 ICD-10: G11.3 Clinical summary This test identifies pathogenic variants in the ATM gene, confirming a diagnosis of Ataxia-Telangiectasia.
TEST-5381 ATL3 Gene Hereditary Sensory Neuropathy Type 1F (HSN1F) Genetic Test This test identifies pathogenic variants in the ATL3 gene associated with Hereditary Sensory Neuropathy Type 1F (HSN1F). It uses Next-Generation Sequencing (NGS) and Sanger confirm...	Whole blood (EDTA), extracted DNA, or FTA card	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ATL3 gene", "Full coding region plus ±5 bp flanking intronic sequences"] Parameters [] Preparation ["Fasting is not required", "Maintain usual routine"] Indications ["Suspected Hereditary Sensory Neuropathy Type 1F (HSN1F)", "Autosomal dominant sensory neuropathy"] Measurement technique Confirm with laboratory Codes LOINC: 82287-9 ICD-10: G60.8 Clinical summary This test identifies pathogenic variants in the ATL3 gene associated with Hereditary Sensory Neuropathy Type 1F (HSN1F). It uses Next-Generation Sequencing (NGS) and Sanger confirmation for high diagnostic sensitivity.
TEST-3679 ATP7A Gene Menkes Disease Genetic Test This genetic test evaluates the ATP7A gene for mutations associated with Menkes disease.	Peripheral Whole Blood (also accepted: Dried Blood Spot on FTA card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ATP7A gene sequence", "Mutations within the ATP7A gene"] Parameters [] Preparation ["No specific fasting required.", "Inform the lab of any relevant family history."] Indications ["Suspected Menkes disease based on clinical presentation", "Family history of Menkes disease", "Need for definitive genetic diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 101717-5 ICD-10: E83.0, Z13.79, Z84.81 Clinical summary This genetic test evaluates the ATP7A gene for mutations associated with Menkes disease.
TEST-5835 ATP7A Gene Spinal Muscular Atrophy, Distal, X-linked DNA Test (NGS) This diagnostic test evaluates the ATP7A gene for pathogenic variants associated with X-linked distal spinal muscular atrophy (SMAX2). It identifies single nucleotide variants, sma...	Peripheral Blood (EDTA), Extracted DNA, or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ATP7A gene sequence", "Copy Number Variants (CNVs) in ATP7A gene"] Parameters [] Preparation ["No specific fasting required", "Inform the lab of any recent blood transfusions ( Indications ["Suspected diagnosis of X-linked distal spinal muscular atrophy (SMAX2)", "Family history of SMAX2", "Carrier screening for at-risk female relatives", "Family planning and reproductive counseling"] Measurement technique Confirm with laboratory Codes LOINC: 82335-1 ICD-10: G12.9 Clinical summary This diagnostic test evaluates the ATP7A gene for pathogenic variants associated with X-linked distal spinal muscular atrophy (SMAX2). It identifies single nucleotide variants, small insertions/deletions, and copy number changes.
TEST-4021 ATP8A2 Gene Cerebellar Ataxia, Mental Retardation, and Dysequilibrium Syndrome Type 4 (CAMRQ4) Genetic Test This genetic test evaluates the ATP8A2 gene for pathogenic variants associated with Cerebellar Ataxia, Mental Retardation, and Dysequilibrium Syndrome Type 4 (CAMRQ4).	Peripheral whole blood (EDTA) or saliva	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ATP8A2 gene", "Coding region sequence analysis"] Parameters [] Preparation ["Mandatory genetic counselling session", "No fasting required", "No medication adjustment needed"] Indications ["Individuals with clinical features suggestive of CAMRQ4", "Family history of CAMRQ4", "Differential diagnosis of cerebellar ataxia and intellectual disability"] Measurement technique Confirm with laboratory Codes LOINC: 81313-4 ICD-10: G11.8 Clinical summary This genetic test evaluates the ATP8A2 gene for pathogenic variants associated with Cerebellar Ataxia, Mental Retardation, and Dysequilibrium Syndrome Type 4 (CAMRQ4).
TEST-6107 ATP8B1 Gene Sequencing for Benign Recurrent Intrahepatic Cholestasis (BRIC) Test This test identifies pathogenic variants in the ATP8B1 gene associated with benign recurrent intrahepatic cholestasis (BRIC).	Peripheral blood (EDTA whole blood)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ATP8B1 gene variants", "Pathogenic mutations"] Parameters [] Preparation ["No fasting required", "Completed clinical history form needed", "Pre-genetic counselling session required"] Indications ["Suspected benign recurrent intrahepatic cholestasis (BRIC)", "Family history of BRIC"] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: K76.89 Clinical summary This test identifies pathogenic variants in the ATP8B1 gene associated with benign recurrent intrahepatic cholestasis (BRIC).
TEST-2348 ATRIP Gene Seckel Syndrome Genetic Test This genetic test detects pathogenic variants in the ATRIP gene associated with Seckel syndrome.	Peripheral Blood, Extracted DNA, or Dried Blood Spot (FTA Card)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ATRIP gene"] Parameters [] Preparation [] Indications ["Clinical suspicion of Seckel syndrome", "Evaluation of dysmorphology", "Genetic counseling"] Measurement technique Confirm with laboratory Codes LOINC: 92895-0 ICD-10: Q87.1 Clinical summary This genetic test detects pathogenic variants in the ATRIP gene associated with Seckel syndrome.
TEST-4787 ATRX Gene (X‑Linked Intellectual Disability with Hypotonic Facies Syndrome) Genetic Test This test identifies pathogenic variants, including single-nucleotide variants, indels, and copy-number changes, within the entire coding region of the ATRX gene.	Whole Blood (EDTA) or Dried Blood Spot (FTA Card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Single-nucleotide variants (SNVs)", "Insertions/Deletions (Indels)", "Copy Number Variations (CNVs)"] Parameters [] Preparation ["No fasting required", "Do not discontinue prescribed medication without consulting a doctor"] Indications ["Suspected X-linked intellectual disability with hypotonic facies syndrome", "Neurodevelopmental disorders with unknown etiology"] Measurement technique Confirm with laboratory Codes LOINC: 96536-3 ICD-10: Q87.8 Clinical summary This test identifies pathogenic variants, including single-nucleotide variants, indels, and copy-number changes, within the entire coding region of the ATRX gene.
TEST-3084 ATRX Gene Alpha‑Thalassemia/Mental Retardation Syndrome Genetic Test This test evaluates the ATRX gene for pathogenic variants associated with Alpha‑Thalassemia/Mental Retardation Syndrome (ATR‑X). It uses Next-Generation Sequencing (NGS) for compre...	Whole Blood (EDTA tube), Extracted DNA, or FTA Card (one drop)	3-4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ATRX gene", "Single Nucleotide Variants (SNVs)", "Insertions/Deletions (indels)", "Copy Number Variations (CNVs)"] Parameters [] Preparation ["No special preparation required", "May eat and drink normally", "Continue prescribed medications"] Indications ["Clinical suspicion of ATR‑X syndrome", "Confirmation of diagnosis", "Genetic counseling"] Measurement technique Confirm with laboratory Codes LOINC: 81170-3 ICD-10: Q87.8, D56.0, F78.9 Clinical summary This test evaluates the ATRX gene for pathogenic variants associated with Alpha‑Thalassemia/Mental Retardation Syndrome (ATR‑X). It uses Next-Generation Sequencing (NGS) for comprehensive analysis.
TEST-5266 BAG3 Gene Myopathy (Myofibrillar Myopathy Type 6) Genetic Test This genetic test detects mutations in the BAG3 gene associated with Myofibrillar Myopathy Type 6.	Peripheral whole blood (EDTA), extracted DNA, or FTA card	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic mutations in the BAG3 gene", "Point mutations", "Small insertions/deletions", "Copy-number variations (CNVs)"] Parameters [{"name": "Analytical Sensitivity", "reference_range": "99.9%"}] Preparation ["No fasting required", "No medication changes required unless directed by a doctor", "Pre-test genetic counselling session mandatory"] Indications ["Suspected diagnosis of BAG3-related myofibrillar myopathy", "Patients with clinical features consistent with myofibrillar myopathy", "Family members of individuals diagnosed with BAG3 mutations"] Measurement technique Confirm with laboratory Codes LOINC: 48019-2 ICD-10: G71.09, Z13.71 Clinical summary This genetic test detects mutations in the BAG3 gene associated with Myofibrillar Myopathy Type 6.
TEST-2770 BCL9L Gene Heterotaxy, Visceral, BCL9L Related Genetic Test This genetic test analyzes the BCL9L gene for pathogenic variants associated with visceral heterotaxy and congenital laterality defects.	Peripheral Whole Blood	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the BCL9L gene"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications"] Indications ["Neonates, children, or adults with congenital heart defects", "Individuals with situs inversus", "Family history of visceral laterality disorders"] Measurement technique Confirm with laboratory Codes LOINC: 104143-7 ICD-10: Q20.3 Clinical summary This genetic test analyzes the BCL9L gene for pathogenic variants associated with visceral heterotaxy and congenital laterality defects.
TEST-2034 BMPR1A Gene Juvenile Polyposis Syndrome Genetic Test This test evaluates the BMPR1A gene for mutations associated with Juvenile Polyposis Syndrome (JPS), a hereditary condition increasing colorectal cancer risk.	Peripheral whole blood (EDTA), extracted DNA, or FTA card blood spot	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["BMPR1A gene mutations", "Single nucleotide variants", "Small insertions/deletions", "Copy number changes"] Parameters [] Preparation ["Genetic counselling session is mandatory before sample collection"] Indications ["Individuals with multiple juvenile polyps", "Family history of JPS or early-onset colorectal cancer", "Suspected hereditary polyposis", "Asymptomatic individuals with a known family mutation"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: Q85.09 Clinical summary This test evaluates the BMPR1A gene for mutations associated with Juvenile Polyposis Syndrome (JPS), a hereditary condition increasing colorectal cancer risk.
TEST-2647 BRAF Gene LEOPARD Syndrome Type 3 Genetic Test This test identifies germline mutations in the BRAF gene associated with LEOPARD syndrome type 3.	Whole blood (EDTA) or FTA card	14–21 working days (3–4 calendar weeks)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Germline mutations in the BRAF gene", "Point mutations", "Small indels", "Copy-number variants"] Parameters [] Preparation ["No fasting required", "Pre-test genetic counselling session mandatory"] Indications ["Suspected LEOPARD syndrome type 3", "Familial risk stratification", "Precise clinical management"] Measurement technique Confirm with laboratory Codes LOINC: 79679-8 ICD-10: Q87.89 Clinical summary This test identifies germline mutations in the BRAF gene associated with LEOPARD syndrome type 3.

Category overview

Genetic Sequencing: overview

Achieving a definitive diagnosis for multi-system or exceptionally rare disorders requires reading the deepest layers of your foundational biological code. As the pinnacle of our advanced Genetics department, Genetic Sequencing (including Whole Exome or Whole Genome testing) provides an incredibly detailed, high-resolution scan of your DNA. By leveraging state-of-the-art Next-Generation Sequencing technology, this expansive molecular screening helps uncover elusive genetic variants that standard tests miss, safely guiding your healthcare provider in tailoring highly personalized medical treatments and opening doors to advanced precision medicine. Consistently trusted for advanced genomic analysis across premier diagnostic labs in Dubai and the UAE, DNA Labs ensures strict patient confidentiality, exceptional analytical precision, and highly efficient reporting. Secure the definitive insights your health requires—book your genetic sequencing testing in UAE, arrange a secure clinical sample collection, or consult our dedicated medical genetics experts.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.